|
DDX19A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.271800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.958000E-02 |
| Normal-vs-Stage2 |
5.302400E-01 |
| Normal-vs-Stage3 |
3.788400E-01 |
| Normal-vs-Stage4 |
2.289200E-01 |
| Stage1-vs-Stage2 |
7.774600E-01 |
| Stage1-vs-Stage3 |
4.824100E-02 |
| Stage1-vs-Stage4 |
6.093200E-01 |
| Stage2-vs-Stage3 |
2.786600E-01 |
| Stage2-vs-Stage4 |
5.649000E-01 |
| Stage3-vs-Stage4 |
1.433440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.414450E-01 |
| Normal-vs-AfricanAmerican |
6.222200E-02 |
| Normal-vs-Asian |
8.319200E-01 |
| Caucasian-vs-AfricanAmerican |
4.109200E-01 |
| Caucasian-vs-Asian |
7.153000E-01 |
| AfricanAmerican-vs-Asian |
6.203000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.395000E-03 |
| Normal-vs-Female |
5.944000E-01 |
| Male-vs-Female |
2.119600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.808480E-02 |
| Normal-vs-Extreme_Weight |
1.083550E-02 |
| Normal-vs-Obese |
6.246400E-01 |
| Normal-vs-Extreme_Obese |
7.739400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.921000E-01 |
| Normal_Weight-vs-Obese |
1.034590E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.435200E-01 |
| Extreme_Weight-vs-Obese |
1.497360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.530000E-01 |
| Obese-vs-Extreme_Obese |
8.941000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.884600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.400760E-01 |
| Normal-vs-Age(61-80Yrs) |
1.559210E-01 |
| Normal-vs-Age(81-100Yrs) |
1.654070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.377400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.786600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.219170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.774200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.935800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.312600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.002000E-03 |
| Normal-VS-Type2 PRCC |
6.623000E-01 |
| Normal-VS-KIRP CIMP |
5.420200E-01 |
| Normal-VS-Unclassified PRCC |
3.219800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.279400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.033760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.159850E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.572800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.887800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.090200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.045250E-01 |
| Normal-vs-N1 |
5.527800E-01 |
| Normal-vs-N2 |
5.458200E-02 |
| N0-vs-N1 |
1.377220E-01 |
| N0-vs-N2 |
2.184000E-01 |
| N1-vs-N2 |
3.017900E-02 |
|
|
